HRTS Holdings
46 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | ELI LILLY & CO | 11.59% | 5,191 | $6.2M |
| 2 | THERMO FISHER SCIENTIFIC INC | 5.70% | 4,586 | $3.0M |
| 3 | UNITEDHEALTH GROUP INC | 4.79% | 6,779 | $2.5M |
| 4 | MERCK & CO INC | 4.33% | 16,125 | $2.3M |
| 5 | ROCHE HOLDING AG (RHHBY) | 3.93% | 38,717 | $2.1M |
| 6 | NOVO NORDISK A/S (NOVO-B.CO) | 3.76% | 52,620 | $2.0M |
| 7 | REVOLUTION MEDICINES INC | 3.73% | 9,885 | $2.0M |
| 8 | JOHNSON & JOHNSON | 3.35% | 6,907 | $1.8M |
| 9 | GILEAD SCIENCES INC | 3.26% | 11,805 | $1.7M |
| 10 | KODIAK SCIENCES INC | 3.17% | 18,529 | $1.7M |
| 11 | DANAHER CORP | 3.16% | 7,704 | $1.7M |
| 12 | CYTOKINETICS INC | 3.15% | 27,464 | $1.7M |
| 13 | BRIDGEBIO PHARMA INC | 3.10% | 24,840 | $1.7M |
| 14 | ASTRAZENECA PLC (AZN.L) | 2.99% | 9,903 | $1.6M |
| 15 | VERTEX PHARMACEUTICALS INC | 2.91% | 3,059 | $1.5M |
| 16 | ABBOTT LABORATORIES | 2.87% | 15,497 | $1.5M |
| 17 | NOVARTIS AG (NOVN.SW) | 2.74% | 10,132 | $1.5M |
| 18 | ABBVIE INC | 2.58% | 5,054 | $1.4M |
| 19 | INTUITIVE SURGICAL INC | 2.48% | 3,179 | $1.3M |
| 20 | MEDTRONIC PLC | 2.08% | 12,942 | $1.1M |
| 21 | MCKESSON CORP | 2.01% | 1,175 | $1.1M |
| 22 | BRISTOL-MYERS SQUIBB CO | 1.84% | 16,378 | $977.8K |
| 23 | OTSUKA HOLDINGS CO LTD (4578.T) | 1.51% | 11,052 | $802.4K |
| 24 | DEXCOM INC | 1.50% | 9,478 | $799.0K |
| 25 | STRYKER CORP | 1.40% | 2,715 | $747.7K |
Sector Weights
- Healthcare: 100.00%
Country Weights
- United States: 79.26%
- Switzerland: 6.67%
- Denmark: 4.12%
- United Kingdom: 2.99%
- Ireland: 2.08%
- Japan: 2.50%
- Israel: 1.21%
- Other: 0.60%
- Canada: 0.56%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.